Home > Qtrly Results > Alkem Laboratories

Alkem Laboratories
Quarterly Results Analysis [Jun2022]

Alkem Laboratories is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for Alkem Laboratories
Please provide your vote to see the results

Alkem Laboratories Quarterly Results

Consolidated Jun2022
UnAudited
Mar2022
Audited
Dec2021
UnAudited
Sep2021
Audited
Jun2021
Audited
Mar2021
Audited
Dec2020
UnAudited
Sep2020
Audited
Revenues ₹2,576 Cr ₹2,484 Cr ₹2,619 Cr ₹2,800 Cr ₹2,731 Cr ₹2,192 Cr ₹2,318 Cr ₹2,363 Cr
Expenses ₹2,373 Cr ₹2,147 Cr ₹2,121 Cr ₹2,176 Cr ₹2,139 Cr ₹1,901 Cr ₹1,789 Cr ₹1,762 Cr
Operating Income ₹203 Cr ₹337 Cr ₹498 Cr ₹624 Cr ₹593 Cr ₹291 Cr ₹529 Cr ₹600 Cr
Other Income ₹51 Cr ₹21 Cr ₹54 Cr ₹42 Cr ₹47 Cr ₹46 Cr ₹96 Cr ₹36 Cr
Interest ₹27 Cr ₹17 Cr ₹11 Cr ₹12 Cr ₹13 Cr ₹11 Cr ₹13 Cr ₹18 Cr
Depreciation ₹76 Cr ₹83 Cr ₹77 Cr ₹73 Cr ₹71 Cr ₹69 Cr ₹69 Cr ₹70 Cr
Profit Before Tax ₹152 Cr ₹243 Cr ₹464 Cr ₹582 Cr ₹556 Cr ₹258 Cr ₹543 Cr ₹548 Cr
Profit After Tax ₹131 Cr ₹108 Cr ₹533 Cr ₹559 Cr ₹480 Cr ₹249 Cr ₹464 Cr ₹482 Cr
EPS ₹10.68 ₹9.00 ₹43.97 ₹45.53 ₹39.16 ₹20.07 ₹37.72 ₹39.49
Industry Peers & Returns1W1M1Y
Alkem Laboratories -0.6% -8.5% -19.1%
SUN PHARMACEUTICAL INDUSTRIES 0.1% 4.8% 17.4%
DIVIS LABORATORIES -5% 0.6% -24.6%
DR REDDYS LABORATORIES 1.8% -4.9% -9.9%
CIPLA -1.2% 6.2% 14.2%
GLAND PHARMA 2.7% -3.9% -45.8%
PIRAMAL ENTERPRISES 8.4% 19% -29.1%
CADILA HEALTHCARE 9.6% 7.7% -26.8%
TORRENT PHARMACEUTICALS 1.1% 2.7% 8.1%

Alkem Laboratories Quarterly Revenues

Revenues
Q-o-Q

3.72 %

Y-o-Y

-5.67 %

Quarters Revenues % Change
Jun2022 ₹2,576 Cr
3.72
Mar2022 ₹2,484 Cr
-5.16
Dec2021 ₹2,619 Cr
-6.46
Sep2021 ₹2,800 Cr
2.51
Jun2021 ₹2,731 Cr
24.60
Mar2021 ₹2,192 Cr
-5.43
Dec2020 ₹2,318 Cr
-1.89
Sep2020 ₹2,363 Cr -

Alkem Laboratories Quarterly Operating Profit

Operating Profit
Q-o-Q

-39.73 %

Y-o-Y

-65.72 %

Quarters Operating Profit % Change
Jun2022 ₹203 Cr
-39.73
Mar2022 ₹337 Cr
-32.34
Dec2021 ₹498 Cr
-20.17
Sep2021 ₹624 Cr
5.32
Jun2021 ₹593 Cr
103.66
Mar2021 ₹291 Cr
-44.98
Dec2020 ₹529 Cr
-11.89
Sep2020 ₹600 Cr -
Operating Margins
Q-o-Q

-41.90 %

Y-o-Y

-63.66 %

Quarters Operating Margin% % Change
Jun2022 7.89%
-41.90
Mar2022 13.58%
-28.64
Dec2021 19.03%
-14.66
Sep2021 22.3%
2.72
Jun2021 21.71%
63.48
Mar2021 13.28%
-41.83
Dec2020 22.83%
-10.15
Sep2020 25.41% -

Alkem Laboratories Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

21.48 %

Y-o-Y

-72.63 %

Quarters Profit After Tax % Change
Jun2022 ₹131 Cr
21.48
Mar2022 ₹108 Cr
-79.71
Dec2021 ₹533 Cr
-4.51
Sep2021 ₹559 Cr
16.30
Jun2021 ₹480 Cr
92.69
Mar2021 ₹249 Cr
-46.27
Dec2020 ₹464 Cr
-3.67
Sep2020 ₹482 Cr -
PAT Margins
Q-o-Q

16.97 %

Y-o-Y

-70.99 %

Quarters PAT Margin(%) % Change
Jun2022 5.1 %
16.97
Mar2022 4.36 %
-78.59
Dec2021 20.36 %
2.06
Sep2021 19.95 %
13.48
Jun2021 17.58 %
54.62
Mar2021 11.37 %
-43.18
Dec2020 20.01 %
-1.82
Sep2020 20.38 % -

Alkem Laboratories Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

18.67 %

Y-o-Y

-72.73 %

Quarters EPS % Change
Jun2022 ₹10.68
18.67
Mar2022 ₹9
-79.53
Dec2021 ₹43.97
-3.43
Sep2021 ₹45.53
16.27
Jun2021 ₹39.16
95.12
Mar2021 ₹20.07
-46.79
Dec2020 ₹37.72
-4.48
Sep2020 ₹39.49 -

You may also like the below Video Courses


SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].